These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31350240)

  • 41. A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data.
    Schneider G; Kachroo S; Jones N; Crean S; Rotella P; Avetisyan R; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():248-55. PubMed ID: 22262613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of incident pancreatic cancer in Ontario administrative health data: A validation study.
    Wu JW; Azoulay L; Huang A; Paterson M; Wu F; Secrest MH; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():78-85. PubMed ID: 30288856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database.
    Lee CK; Ha HJ; Oh SJ; Kim JW; Lee JK; Kim HS; Yoon SM; Kang SB; Kim ES; Kim TO; Na SY; Lee J; Kim SW; Koo HS; Park BK; Lee HH; Kim ES; Park JJ; Kwak MS; Cha JM; Ye BD; Choi CH; Kim HJ
    J Gastroenterol Hepatol; 2020 May; 35(5):760-768. PubMed ID: 31498502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany.
    Jacobs E; Hoyer A; Brinks R; Kuss O; Rathmann W
    Diabetes Care; 2017 Dec; 40(12):1703-1709. PubMed ID: 28993421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.
    Dore DD; Liang C; Ziyadeh N; Norman H; Bayliss M; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():29-36. PubMed ID: 22552977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification in administrative databases of women dying of breast cancer.
    Gagnon B; Mayo NE; Laurin C; Hanley JA; McDonald N
    J Clin Oncol; 2006 Feb; 24(6):856-62. PubMed ID: 16484694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of hospital claims databases from care units for estimating thyroid cancer incidence in the Rhône-Alpes region of France].
    Hafdi-Nejjari Z; Couris CM; Schott AM; Perrot L; Bourgoin F; Borson-Chazot F; Sassolas G
    Rev Epidemiol Sante Publique; 2006 Oct; 54(5):391-8. PubMed ID: 17149160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of medical service insurance claims as a surrogate for ascertaining vitiligo cases.
    Bell M; Lui H; Lee TK; Kalia S
    Arch Dermatol Res; 2023 Apr; 315(3):541-550. PubMed ID: 36173455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.
    Quinlan SC; Cheng WY; Ishihara L; Irizarry MC; Holick CN; Duh MS
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):413-21. PubMed ID: 26889887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of an Algorithm to Identify Venous Thromboembolism in Health Insurance Claims Data Among Patients with Rheumatoid Arthritis.
    Kim S; Martin C; White J; Carlyle M; Bui B; Gao S; Salinas CA
    Clin Epidemiol; 2023; 15():671-682. PubMed ID: 37284517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.
    Xu Y; Kong S; Cheung WY; Bouchard-Fortier A; Dort JC; Quan H; Buie EM; McKinnon G; Quan ML
    BMC Cancer; 2019 Mar; 19(1):210. PubMed ID: 30849954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims Database.
    Hashibe M; Ou JY; Herget K; Bolton D; McPherson J; Hawley C; Garvin J; Doherty JA; Sweeney C
    JCO Clin Cancer Inform; 2019 Oct; 3():1-10. PubMed ID: 31756128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two approaches to linking census and hospital data.
    Rotermann M; Sanmartin C; Carrière G; Trudeau R; St-Jean H; Saïdi A; Reicker A; Ntwari A; Hortop E
    Health Rep; 2014 Oct; 25(10):3-14. PubMed ID: 25317754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
    Fu AZ; Jhaveri M
    J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using personal health insurance numbers to link the Canadian Cancer Registry and the Discharge Abstract Database.
    Zakaria D; Trudeau R; Sanmartin C; Murison P; Carrière G; MacIntyre M; Turner D; Wagar B; King MJ; Vriends K; Woods R; Lockwood G; Louchini R
    Health Rep; 2015 Jun; 26(6):3-11. PubMed ID: 26086334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a case definition to define chronic dialysis using outpatient administrative data.
    Clement FM; James MT; Chin R; Klarenbach SW; Manns BJ; Quinn RR; Ravani P; Tonelli M; Hemmelgarn BR;
    BMC Med Res Methodol; 2011 Mar; 11():25. PubMed ID: 21362182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of patients with diabetic macular edema from claims data: a validation study.
    Bearelly S; Mruthyunjaya P; Tzeng JP; Suñer IJ; Shea AM; Lee JT; Kowalski JW; Curtis LH; Schulman KA; Lee PP
    Arch Ophthalmol; 2008 Jul; 126(7):986-9. PubMed ID: 18625948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying and classifying people with disabilities using claims data: further development of the Access Risk Classification System (ARCS) algorithm.
    Palsbo SE; Sutton CD; Mastal MF; Johnson S; Cohen A
    Disabil Health J; 2008 Oct; 1(4):215-23. PubMed ID: 21122732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
    Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
    Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.